BioCardia
Financial ratios & Valuation

Historical Multiples (2014 – 2023)

2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 TTM Median
Valuation Ratios
Price/Earnings ratio
8.694.65-10.52-7.28-3.31-1.40-2.33-2.60-3.10-1.21-706.59-1.40
Price/Sales ratio
4.762.89188.36187.2173.6829.25241.4532.3327.3929.485.25K73.68
Price/Book Value ratio
0.150.105.278.0612.148.761.823.167.57-8.772.56K12.14
Price/Cash Flow ratio
9.504.52-19.64-10.34-4.16-2.19-2.83-3.16-3.50-1.41-777.16-2.19
Price/Free Cash Flow ratio
12.637.27-19.64-10.18-4.13-2.16-2.82-3.13-3.48-1.40-771.23-2.16
Price/Earnings Growth ratio
0.000.120.010.09-0.270.070.050.050.310.064.12M-0.27
Dividend Yield
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Profitability Indicator Ratios
Gross Profit Margin
100%100%-29.51%-44.05%17.28%49.57%97.24%36.94%-780.25%-1519.70%N/A49.57%
Operating Profit Margin
54.09%61.70%-1320.83%-2589.77%-2256.31%-2001.83%-10709.65%-1244.33%-880.25%-2441.09%-244.04%-2256.31%
Pretax Profit Margin
54.80%62.28%-1789.93%-2569.51%-2237.92%-2071.69%-10347.58%-1243.64%-880.69%-2425.78%-743.04%-2237.92%
Net Profit Margin
54.80%62.28%-1789.93%-2569.51%-2219.52%-2087.18%-10348.27%-1243.44%-881.13%-2425.78%-743.04%-2219.52%
Effective Tax Rate
-2.56%-1.86%-52.39%1.55%0.82%-0.74%-0.00%0.01%-0.05%N/AN/A-0.74%
Return on Assets
1.72%2.32%-46.68%-90.91%-216.17%-193.00%-64.05%-80.29%-121.64%-387.37%-181.03%-216.17%
Return On Equity
1.72%2.32%-50.09%-110.63%-365.82%-625.27%-78.24%-121.64%-243.52%721.83%-307.10%-365.82%
Return on Capital Employed
1.70%2.30%-36.86%-110.69%-364.48%-386.74%-80.98%-105.19%-191.70%1875.04%-93.79%-364.48%
Liquidity Ratios
Current Ratio
N/AN/AN/AN/AN/A1.595.33N/AN/AN/A2.191.59
Quick Ratio
12.86K1.31K15.085.622.381.595.533.632.240.402.101.59
Cash ratio
13.50K1.38K14.785.442.101.395.033.462.050.302.051.39
Days of Sales Outstanding
N/AN/A46.8972.39160.0175.572.13K52.8654.2648.2030.7475.57
Days of Inventory outstanding
N/AN/A66.05101.0399.544.07-77.56K0.00-6.16N/AN/A4.07
Operating Cycle
N/AN/A112.94173.42259.5679.64-75.42K52.8648.0948.20N/A79.64
Days of Payables Outstanding
N/AN/A256.86477.14720.11931.8768.07K289.1420.9442.04N/A931.87
Cash Conversion Cycle
N/AN/A-143.92-303.71-460.55-852.22-143.49K-236.2827.156.16N/A-460.55
Debt Ratios
Debt Ratio
N/A0.40N/AN/AN/A0.060.020.010.030.110.500.50
Debt Equity Ratio
N/A0.40N/AN/AN/A0.220.030.020.06-0.201.001.00
Long-term Debt to Capitalization
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/A0.21N/A
Total Debt to Capitalization
N/A0.29N/AN/AN/A0.180.030.020.06-0.260.250.25
Interest Coverage Ratio
N/AN/AN/AN/AN/A-131.33-5.00KN/AN/AN/AN/A-131.33
Cash Flow to Debt Ratio
N/A0.05N/AN/AN/A-17.88-20.12-43.73-33.52-29.95-9.88-9.88
Company Equity Multiplier
1.001.001.071.211.693.231.221.512.00-1.862.001.69
Cash Flow Ratios
Operating Cash Flow / Sales Ratio
0.500.64-9.58-18.10-17.71-13.30-85.22-10.21-7.81-20.90-6.75-17.71
Free Cash Flow / Operating Cash Flow Ratio
0.750.6211.011.001.011.001.011.001.001.001.00
Cash Flow Coverage Ratio
N/A0.05N/AN/AN/A-17.88-20.12-43.73-33.52-29.95-9.88-9.88
Short Term Coverage Ratio
N/A0.05N/AN/AN/A-17.88-20.12-43.73-33.52-29.95-51.17-17.88
Dividend Payout Ratio
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A